Cyclophilin D as a potential target for antioxidants in neurodegeneration: The X-ALD case

Biological Chemistry

Volumn 394, Issue 5, 2013, Pages 621-629

  López Erauskin, Jone ^a   Ferrer, Isidre ^a   Galea, Elena ^b,c   Pujol, Aurora ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cyclophilin D; Mitochondrial permeability transition pore; Neurodegeneration; Oxidative stress; Very long chain fatty acids; X linked adrenoleukodystrophy

Indexed keywords

ANTIOXIDANT; CYCLOPHILIN D; FATTY ACID TRANSPORTER; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; VERY LONG CHAIN FATTY ACID;

ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; CHILDHOOD ADRENOLEUKODYSTROPHY; CLINICAL FEATURE; CONFERENCE PAPER; ENZYME METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RARE DISEASE;

ADRENOLEUKODYSTROPHY; ANIMALS; ANTIOXIDANTS; CLINICAL TRIALS, PHASE II AS TOPIC; COENZYME A LIGASES; CYCLOPHILINS; HUMANS; MOLECULAR TARGETED THERAPY; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 84881641668     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0323     Document Type: Conference Paper

References (72)

1. Baarine, M., Andréoletti, P., Athias, A., Nury, T., Zarrouk, A., Ragot, K., Vejux, A., Riedinger, J.M., Kattan, Z., Bessede, G., et al. (2012a). Evidence of oxidative stress in very long chain fatty acid-treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins. Neuroscience 213, 1-18.
2. Baarine, M., Ragot, K., Athias, A., Nury, T., Kattan, Z., Genin, E.C., Andreoletti, P., Ménétrier, F., Riedinger, J.M., Bardou, M., et al. (2012b). Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-a on oligodendrocytes and astrocytes. Neurotoxicology 33, 212-228.
3. Baines, C.P., Kaiser, R.A., Purcell, N.H., Blair, N.S., Osinska, H., Hambleton, M.A., Brunskill, E.W., Sayen, M.R., Gottlieb, R.A., Dorn, G.W., et al. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662. (Pubitemid 40488559)
4. Berger, J. and Gartner, J. (2006). X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim. Biophys. Acta 1763, 1721-1732. (Pubitemid 44880457)
5. Berger, J., Pujol, A., Aubourg, P., and Forss-Petter, S. (2010). Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy. Brain Pathol. 20, 845-856.
6. Bernardi, P., Krauskopf, A., Basso, E., Petronilli, V., Blachly-Dyson, E., Di Lisa, F., and Forte, M.A. (2006). The mitochondrial permeability transition from in vitro artifact to disease target. Febs J 273, 2077-2099.
7. Bezman, L., Moser, A.B., Raymond, G.V., Rinaldo, P., Watkins, P.A., Smith, K.D., Kass, N.E., and Moser, H.W. (2001). Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann. Neurol. 49, 512-517. (Pubitemid 32281335)
8. Blackstone, C. and Chang, C.R. (2011). Mitochondria unite to survive. Nat Cell Biol 13, 521-522.
9. Connern, C.P. and Halestrap, A.P. (1994). Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem. J. 302 (Pt 2), 321-324. (Pubitemid 24280079)
10. Crompton, M., Ellinger, H., and Costi, A. (1988). Inhibition by cyclosporin A of a Ca 2 + -dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J. 255, 357-360.
11. Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A.A., McKhann, G.M., Yan, Y., Wang, C., Zhang, H., Molkentin, J.D., et al. (2008). Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med. 14, 1097-1105.
12. Du, H. and Yan, S.S. (2010). Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid b. Biochim. Biophys. Acta 1802, 198-204.
13. Eichler, F.S., Ren, J.Q., Cossoy, M., Rietsch, A.M., Nagpal, S., Moser, A.B., Frosch, M.P., and Ransohoff, R.M. (2008). Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann. Neurol. 63, 729-742. (Pubitemid 351945532)
14. Engelen, M., Kemp, S., de Visser, M., van Geel, B.M., Wanders, R.J., Aubourg, P., and Poll-The, B.T. (2012). X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet. J. Rare Dis. 7, 51, 1-14.
15. Fernandez-Checa, J.C., Fernandez, A., Morales, A., Mari, M., Garcia-Ruiz, C., and Colell, A. (2010). Oxidative stress and altered mitochondrial function in neurodegenerative diseases: lessons from mouse models. CNS Neurol. Disord. Drug Targets 9, 439-454.
16. Ferrer, I., Aubourg, P., and Pujol, A. (2010). General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol. 20, 817-830.
17. Ferrer, I., Kapfhammer, J.P., Hindelang, C., Kemp, S., Troffer- Charlier, N., Broccoli, V., Callyzot, N., Mooyer, P., Selhorst, J., Vreken, P., et al. (2005). Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage. Hum. Mol. Genet. 14, 3565-3577. (Pubitemid 41754658)
18. Forss-Petter, S., Werner, H., Berger, J., Lassmann, H., Molzer, B., Schwab, M.H., Bernheimer, H., Zimmermann, F., and Nave, K.A. (1997). Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J. Neurosci. Res. 50, 829-843.
19. Forte, M., Gold, B.G., Marracci, G., Chaudhary, P., Basso, E., Johnsen, D., Yu, X., Fowlkes, J., Rahder, M., Stem, K., et al. (2007). Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 104, 7558-7563. (Pubitemid 47185945)
20. Fourcade, S., Lopez-Erauskin, J., Galino, J., Duval, C., Naudi, A., Jove, M., Kemp, S., Villarroya, F., Ferrer, I., Pamplona, R., et al. (2008). Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum. Mol. Genet. 17, 1762-1773. (Pubitemid 351791502)
21. Fourcade, S., Ruiz, M., Camps, C., Schluter, A., Houten, S.M., Mooyer, P.A., Pàmpols, T., Dacremont, G., Wanders, R.J., Girò s, M., et al. (2009). A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am. J. Physiol. Endocrinol. Metab. 296, E211 - E221.
22. Fourcade, S., Ruiz, M., Guilera, C., Hahnen, E., Brichta, L., Naudi, A., Portero-Otín, M., Dacremont, G., Cartier, N., Wanders, R., et al. (2010). Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy. Hum. Mol. Genet. 19, 2005-2014.
23. Galea, E., Launay, N., Portero-Otin, M., Ruiz, M., Pamplona, R., Aubourg, P., Ferrer, I., and Pujol, A. (2012). Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases? Biochim. Biophys. Acta 1822, 1475-1488.
24. Galino, J., Ruiz, M., Fourcade, S., Schluter, A., Lopez-Erauskin, J., Guilera, C., Jove, M., Naudi, A., García-Arum í, E., Andreu, A.L., et al. (2011). Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of x-adrenoleukodystrophy. Antioxid. Redox Signal. 15, 2095-2107.
25. Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D.S., Tabrizi, S.J., Wood, N.W., et al. (2009). PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol. Cell 33, 627-638.
26. Garashi, M., Belchis, D., and Suzuki, K. (1976). Brain gangliosides in adrenoleukodystrophy. J. Neurochem. 27, 327-328.
27. Halestrap, A. (2005). Biochemistry: a pore way to die. Nature 434, 578-579. (Pubitemid 40488541)
28. Halestrap, A.P. (2009). What is the mitochondrial permeability transition pore? J. Mol. Cell Cardiol. 46, 821-831.
29. Halestrap, A.P. and Davidson, A.M. (1990). Inhibition of Ca 2 + - induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem. J. 268, 153-160. (Pubitemid 20166664)
30. Hein, S., Schonfeld, P., Kahlert, S., and Reiser, G. (2008). Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum. Mol. Genet. 17, 1750-1761. (Pubitemid 351791501)
31. Hubbard, W.C., Moser, A.B., Tortorelli, S., Liu, A., Jones, D., and Moser, H. (2006). Combined liquid chromatographytandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. Mol. Genet. Metab. 89, 185-187. (Pubitemid 44205475)
32. Karlsson, J., Fong, K.S., Hansson, M.J., Elmer, E., Csiszar, K., and Keep, M.F. (2004). Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosurg. 101, 128-137. (Pubitemid 38808472)
33. Kobayashi, T., Shinnoh, N., Kondo, A., and Yamada, T. (1997). Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem. Biophys. Res. Commun. 232, 631-636. (Pubitemid 27214048)
34. Laureti, S., Casucci, G., Santeusanio, F., Angeletti, G., Aubourg, P., and Brunetti, P. (1996). X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients. J. Clin. Endocrinol. Metab. 81, 470-474. (Pubitemid 26057571)
35. Lin, M.T. and Beal, M.F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795. (Pubitemid 44622683)
36. Linard, D., Kandlbinder, A., Degand, H., Morsomme, P., Dietz, K.J., and Knoops, B. (2009). Redox characterization of human cyclophilin D: identification of a new mammalian mitochondrial redox sensor? Arch. Biochem. Biophys. 491, 39-45.
37. Lopez-Erauskin, J., Fourcade, S., Galino, J., Ruiz, M., Schluter, A., Naudi, A., Jove, M., Portero-Otin, M., Pamplona, R., Ferrer, I., et al. (2011). Antioxidants halt axonal degeneration in a mouse model of X- adrenoleukodystrophy. Ann. Neurol. 70, 84-92.
38. Lopez-Erauskin, J., Galino, J., Bianchi, P., Fourcade, S., Andreu, A.L., Ferrer, I., Mu ñ oz-Pinedo, C., and Pujol, A. (2012). Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy. Brain 135, 3584-3598.
39. Lu, J.F., Lawler, A.M., Watkins, P.A., Powers, J.M., Moser, A.B., Moser, H.W., and Smith, K.D. (1997). A mouse model for X-linked adrenoleukodystrophy. Proc. Natl. Acad. Sci. USA 94, 9366-9371. (Pubitemid 27357835)
40. Martin, L.J. (2010). The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy. Biochim. Biophys. Acta 1802, 186-197.
41. Martin, L.J., Gertz, B., Pan, Y., Price, A.C., Molkentin, J.D., and Chang, Q. (2009). The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Exp. Neurol. 218, 333-346.
42. Martinez, A., Portero-Otin, M., Pamplona, R., and Ferrer, I. (2010). Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol. 20, 281-297.
43. Moser, H.W., Mahmood, A., and Raymond, G.V. (2007). X-linked adrenoleukodystrophy. Nat. Clin. Pract. Neurol. 3, 140-151. (Pubitemid 46403941)
44. Mosser, J., Douar, A.M., Sarde, C.O., Kioschis, P., Feil, R., Moser, H., Poustka, A.M., Mandel, J.L., and Aubourg, P. (1993). Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361, 726-730. (Pubitemid 23070480)
45. Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., and Tsujimoto, Y. (2005). Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652-658. (Pubitemid 40488558)
46. Naudi, A., Jove, M., Cacabelos, D., Ramirez, O., Ayala, V., Ilieva, E., Kichev, A., Ferrer, I., Portero-Otin, M., and Pamplona, R. (2011). Membrane unsaturation, selective neuronal vulnerability, and age-related neurodegenerative diseases. In: Lipid Peroxidation: Biological Implications. A. Catala, ed. (Argentina: Universidad Nacional de La Plata), pp. 47-70.
47. Nguyen, T.T., Stevens, M.V., Kohr, M., Steenbergen, C., Sack, M.N., and Murphy, E. (2011). Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J. Biol. Chem. 286, 40184-40192.
48. Pamplona, R. and Barja, G. (2007). Highly resistant macromolecular components and low rate of generation of endogenous damage: two key traits of longevity. Ageing Res. Rev. 6, 189-210. (Pubitemid 47405306)
49. Peters, C., Charnas, L.R., Tan, Y., Ziegler, R.S., Shapiro, E.G., DeFor, T., Grewal, S.S., Orchard, P.J., Abel, S.L., Goldman, A.I., et al. (2004). Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104, 881-888. (Pubitemid 38970588)
50. Petronilli, V., Costantini, P., Scorrano, L., Colonna, R., Passamonti, S., and Bernardi, P. (1994). The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem. 269, 16638-16642.
51. Powers, J.M. and Moser, H.W. (1998). Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol. 8, 101-120. (Pubitemid 28055768)
52. Powers, J.M., DeCiero, D.P., Ito, M., Moser, A.B., and Moser, H.W. (2000). Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J. Neuropathol. Exp. Neurol. 59, 89-102. (Pubitemid 30106465)
53. Powers, J.M., Pei, Z., Heinzer, A.K., Deering, R., Moser, A.B., Moser, H.W., Watkins, P.A., and Smith, K.D. (2005). Adreno-leukodystrophy: oxidative stress of mice and men. J. Neuropathol. Exp. Neurol. 64, 1067-1079.
54. Pratico, D. (2008). Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann. N Y Acad. Sci. 1147, 70-78.
55. Pujol, A., Hindelang, C., Callizot, N., Bartsch, U., Schachner, M., and Mandel, J.L. (2002). Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum. Mol. Genet. 11, 499-505. (Pubitemid 34257486)
56. Pujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., P à mpols, T., Gir ò s, M., and Mandel, J.L. (2004). Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum. Mol. Genet. 13, 2997-3006. (Pubitemid 39585232)
57. Schinzel, A.C., Takeuchi, O., Huang, Z., Fisher, J.K., Zhou, Z., Rubens, J., Hetz, C., Danial, N.N., Moskowitz, M.A., and Korsmeyer, S.J. (2005). Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 102, 12005-12010. (Pubitemid 41291119)
58. Schluter, A., Espinosa, L., Fourcade, S., Galino, J., Lopez, E., Ilieva, E., Morat ó, L., Asheuer, M., Cook, T., McLaren, A., et al. (2012). Functional genomic analysis unravels a metabolicinflammatory interplay in adrenoleukodystrophy. Hum. Mol. Genet. 21, 1062-1077.
59. Schonbrunner, E.R., Mayer, S., Tropschug, M., Fischer, G., Takahashi, N., and Schmid, F.X. (1991) Catalysis of protein folding by cyclophilins from different species. J. Biol. Chem. 266, 3630-3635. (Pubitemid 21909259)
60. Shapiro, E., Krivit, W., Lockman, L., Jambaque, I., Peters, C., Cowan, M., Blanche, S., Bordigoni, P., Loes, D., Ziegler, R., et al. (2000). Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 356, 713-718. (Pubitemid 30663240)
61. Shirendeb, U., Reddy, A.P., Manczak, M., Calkins, M.J., Mao, P., Tagle, D.A., and Reddy, P.H. (2011). Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum. Mol. Genet. 20, 1438-1455.
62. Singh, I., Moser, A.E., Moser, H.W., and Kishimoto, Y. (1984). Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes. Pediatr. Res. 18, 286-290. (Pubitemid 14166135)
63. Singh, I. and Pujol, A. (2010). Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol. 20, 838-844.
64. Stack, E.C., Matson, W.R., and Ferrante, R.J. (2008). Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants. Ann. N Y Acad. Sci. 1147, 79-92.
65. Thannickal, V.J. and Fanburg, B.L. (2000). Reactive oxygen species in cell signaling. Am J. Physiol. Lung. Cell Mol. Physiol. 279, L1005-L1028. (Pubitemid 32009487)
66. Thomas, B., Banerjee, R., Starkova, N.N., Zhang, S.F., Calingasan, N.Y., Yang, L., Wille, E., Lorenzo, B.J., Ho, D.J., Beal, M.F., et al. (2011). Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease. Antioxid. Redox Signal. 16, 855-868.
67. van Roermund, C.W., Visser, W.F., Ijlst, L., van Cruchten, A., Boek, M., Kulik, W., Waterham, H.R., and Wanders, R.J. (2008). The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J. 22, 4201-4208.
68. Vargas, C.R., Wajner, M., Sirtori, L.R., Goulart, L., Chiochetta, M., Coelho, D., Latini, A., Llesuy, S., Bello-Klein, A., Giugliani, R., et al. (2004). Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim. Biophys. Acta 1688, 26-32. (Pubitemid 38366303)
69. Wanders R.J., van Roermund C.W., van Wijland M.J., Nijenhuis A.A., Tromp A., Schutgens R.B., Brouwer-Kelder, E.M., Schram, A.W., Tager, J.M., van den Bosch, H., et al. (1987). X-linked adrenoleukodystrophy: defective peroxisomal oxidation of very long chain fatty acids but not of very long chain fatty acyl-CoA esters. Clin. Chim. Acta 165, 321-329. (Pubitemid 17113690)
70. Wang, Y., Yang, J., and Yi, J. (2012). Redox sensing by proteins: oxidative modifications on cysteines and the consequent events. Antioxid. Redox Signal. 16, 649-657.
71. Zarrouk, A., Vejux, A., Nury, T., El Hajj, H.I., Haddad, M., Cherkaoui-Malki, M., Riedinger, J.M., Hammami, M., and Lizard, G. (2012). Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E). Oxid. Med. Cell Longev. 2012, 623257.
72. Zhou, C., Huang, Y., and Przedborski, S. (2008). Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann. N Y Acad. Sci. 1147, 93-104.